Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21a837b6e77981109aa7871f1ca8c2fa |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-62 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23F3-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L2-52 |
filingDate |
2011-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a291506c76991c14d12e6cae33be7259 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6834110d1d88614813fadc9f053baf3b |
publicationDate |
2012-03-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2012056952-A |
titleOfInvention |
Anti-inflammatory agent or food and drink having anti-inflammatory effect |
abstract |
An object of the present invention is to provide a food / beverage product or a pharmaceutical product having an action of inhibiting COX-2 and / or inhibiting PGE2 biosynthesis using a tea compound. [MEANS FOR SOLVING PROBLEMS] Forty kinds of tea compounds separated from green tea, oolong tea and black tea were tested, and as a result of earnest research targeting the enzyme COX-2 and its product PGE2 which cause chronic inflammation, 18 kinds of tea were found. It has been found that the compounds suppress the expression of COX-2 and / or the production of PGE2. [Selection] Figure 1 |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2020523294-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10468657-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7071406-B2 |
priorityDate |
2011-10-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |